. Activated oestrogen receptor in relation to creatine kinase, progesterone receptor and disease recurrence The presence of non-activated ( I ) and activated (2) oestrogen receptor is compared with the activity of creatine kinase (CK) and progesterone receptor (RP) in breast tumours of pre-and post-menopausal patients (a), and with the number of patients with recurrence of disease at the indicated time after surgery (b). Significantly different from (I): * P = 0.039, * * P = 0.018, * * * P = 0.012 by Mann-Whitney U test. Cumulative recurrence significantly different from (I): tz2 = 8.32, P < 0.005.
CK (munits/mg of R P (fmol/mg of protein) protein) (0
(1) cantly elevated levels of CK and RP in tumours that contained such receptors (Table la) . A significant difference in CK activity between tumours that contained activated or non-activated oestrogen receptor was observed regardless of menopausal status. In contrast, a difference in progesterone receptor concentration between tumours containing activated or non-activated oestrogen was observed in postmenopausal patients only. Despite therefore CK and RP each being oestrogen-inducible proteins, their levels in premenopausal tumours are apparently differentially regulated. Recent reports (Howat et al., 1983; Stewart et al., 1983) have not confirmed the association between oestrogen and progesterone receptor status and disease-free interval reported previously (Knight et al., 1977; Pichon et al., 1981) . Similarly, we found no relationship between oestrogen or progesterone receptor status and the proportion of patients remaining disease-free after surgery (data not shown). However, when the oestrogen receptor-positive group of patients were further subdivided according to the presence of activated oestrogen receptor, then a significant decrease in the proportion of patients with recurrence of disease was observed ( Table Ib) . The measurement of activated oestrogen receptor therefore provides prognostic information not obtained by ligand-binding studies alone, and we suggest usually occurring greatly in excess of serum concentrations (Miller et al., 1982; Bradlow et al., 1983; De Boever et ul., 1983; Raju et a/., 1984; Vanluchene et ul., 1984) . Tritiated dehydroepiandrosterone sulphate (DHAS) has been shown to accumulate in cyst fluid after intravenous administration Cyst fluid from women with gross cystic disease ofthe breast contains high levels of several steroid hormones, particularly Abbreviations used: DHAS, dehydroepiandrosterone sulphate; 3a-HSD. 3a-hydroxysteroid dehydrogenase; dansyl, 5-dimethylaminonaphthalene-I-sulphonyl.
unlike several other steroids found in cyst fluid (Bradlow et al., 1983; Raju et al., 1984) . Oestriol-3-sulphate and 5a-androstan-3a, 17b-diol-sulphate occur in cyst fluid at about 2000-fold the concentration observed in serum (Raju et a/., 1984; Vanluchene et al., 1984) , which, together with evi-618th MEETING, LIVERPOOL Table I . 3a-hydroxy-bile acid concentration and percentage distribution in the serum and cyst fluid of women with benign cystic disease of the breast Results are means f S.E.M. (n = 8). Abbreviations: T, taurine conjugation; G, glycine conjugation; C, cholic acid; UDC, ursodeoxycholic acid; CDC, chenodeoxycholic acid; DC, deoxycholic acid; LiC, lithocholic acid. *Significantly different from serum values (P < 0.01, Mann-Whitney I! test).
Bile acidt
Concentration ( dence against transport from the circulation, suggests local synthesis of the steroids. Accumulation may also be influenced by inefficient efflux of steroid from the cyst (Raju et al., 1984) . Active secretion from the plasma cannot be discounted, especially for DHAS, and androgens, including DHAS, can be converted to oestrogens by breast cancer tissue (Jones er al., 1970; Adams & Li. 1975) . During a study of individual bile acids (5g-cholan-24-oic acids) in the serum of women with breast cancer and benign breast disease, cyst fluid and serum were obtained from eight women with gross cystic disease of the breast and analysed using sensitive h.p.1.c. techniques and selective sample preparation procedures (Reid & Baker, 1985; Baker et al., 1986) . Not only were non-sulphated 3a-hydroxy-bile acids detected in cyst fluid but concentrations far exceeded those in serum ( Table 1) . Total non-sulphated 3a-hydroxybile acid levels determined by h.p.1.c. ranged from 31 to 480 nmol/ml in cyst fluid and 2.05 to 5.70 nmol/ml in serum, giving a range of cystlserum ratios of 1 1 to 148 (mean 89). Furthermore, the distribution of individual bile acids was different in the two fluids (Table I) , with cyst fluid having a higher proportion of total glycine conjugates [cyst = 78.9%
1.6 (mean f s.E.M.), serum = 60.9% + 2.8; P < O.OOl] and a lower percentage of total unconjugated bile acids (cyst = 1.9% f 0.5, serum = 27.0% f 3.3; P < 0.001). In three samples studied sulphated bile acids were also observed (total = 18-165nmol/ml), the highest amounts being found in the cyst fluid with the lowest levels of non-sulphated bile acids.
Since dansyl hydrazine reacts with several ketosteroids, and some 3a-hydroxysteroids are substrates for the 3a-hydroxysteroid dehydrogenase (3a-HSD) used in the derivatization procedure (Baker et al., 1986) , quantification of bile acids by this method is potentially susceptible to error due to the presence of these steroids in high concentrations in cyst fluid. Steroid sulphates are only likely to interfere in solvolysed samples analysed for sulphated bile acids, while oestrogens do not form dansyl hydrazones under the conditions used. Testosterone, epiandrosterone, dehydroepiandrosterone, progesterone, epipregnanolone, cortisol and corticosterone formed oximes and did not yield dansyl hydrazones and/or were extracted by the SCX BOND- ELUT column (Baker et al., 1986) . Androsterone, 5a-androstan-3a, 17/?-diol, and 5P-pregnan-3a.20a-diol formed dansyl hydrazones but had different retention times on h.p.1.c. to the bile acids detected in cyst fluid. However, 5/?-androstan-3a-01-17-one (aetiocholanolone), levels of which do not appear to have been reported in cyst fluid, did form a fluorescent 17-oxime derivative which eluted close to glycodeoxycholic acid. Confirmation of the presence of the major bile acids in cyst fluid shown in Table 1 was therefore obtained by h.p.1.c. of the pre-dansyl hydrazine treated 'control' extracts (i.e. without 3a-HSD or sulphatase treatment; Baker el a/., 1986) on an uncapped octadecyl, 5pm radial compression column (Resolve C 18) using isocratic elution with refractive index detection and Trilab 2000 analysis (Reid & Baker, 1982) . The 3a-hydroxy-bile acids were therefore detected as they occur in cyst fluid while ketosteroids are present as oximes. With this system aetiocholanolone-17-oxime eluted earlier than the major glycine conjugated bile acids. The following levels (nmol/ml) of glycocholic, glycochenodeoxycholic and glycodeoxycholic acids were obtained by the two methods (fluorescent/refractive index) in the three cyst fluids suitable for study; glycocholic acid, 72,6179.7, 74. l /84.8, 43.5149.2; glycochenodeoxycholic acid, 1 15.4194.6, 107.1 / I 12.4, 94.2199.4; glycodeoxycholic acid, I74.3/163.8, 149.411 80.7, 47.7148.3. The total cholesterol concentration was also determined using a cholesterol oxidase-colorimetic method (BCL, Lewes, U.K.) and was elevated in six of eight patients studied compared with serum levels (16.1 f 0 . 9 m~ and 5.0 f 0 . 3 m~) .
Further study is required to determine the origin and relevance of the bile acids found in breast cyst fluid.
Controversy has existed over an enzyme reported to synthesize cyclic CMP from CTP; this putative cytidylate cyclase activity was initially reported in murine myeloid leukaemic tumours and normal mouse liver and spleen (Cech et al., 1976; Cech & Ignarro, 1977 , 1978 Ignarro, 1979; Ignarro & Cech, 1979) as capable of converting [a- '* PICTP into a product identified as cyclic [32P]CMP by chromatography, crystallization to specific activity, resistance to hydrolysis by beef heart phosphodiesterase and radioimmunoassay . However, Gaion & Krishna (l978a,b) reported a labelled product, similarly obtained, which initially co-chromatographed with authentic cyclic CMP, but which, on further purification, co-chromatographed not with cyclic CMP but with 5'-CMP and CDP. A third, unidentified product was also obtained, and these authors concluded that no cyclic ["PICMP was formed. Reservations concerning the putative cytidylate cyclase were also expressed by Stone and Murphy (1981) who, using a similar assay system, found several different products which were immunoreactive to anti-cyclic CMP serum. In order to determine conclusively whether cyclic C M P was formed and the nature of any other products formed from CTP by the enzyme preparation, we decided to examine the incubation mixture at the end of the reaction both chromatographically and by means of the fast atom bombardment (f.a.b.) mass spectrometry and collision-induced dissociation (CID)/ mass analysed ion kinetic energy spectrum (m.i.k.e.s.) scanning systems previously used successfully in the identification of cyclic nucleotides (Newton et al., 1983; 1984a ,b,c, 1986a Kingston et al., 1984 Kingston et al., , 1985 .
Cyclase preparations were produced as described previously (Newton et al., 1986b) and incubated in 5 0 m~-T r i s buffer (pH 7.4) in a total volume of 0.5 ml containing 2 mM-CTP for IOmin at 37°C. The reaction was stopped by addition of 55% trichloroacetic acid and precipitated protein removed by centrifugation. F.a.b. mass spectrometric analysis of the supernatant produced a complex spectrum containing a strong ion at m / z 484 corresponding to the protonated molecular ion of CTP. T.I.c., as previously described (Newton et al., 1986h) , of the incubate indicated that in addition to unchanged CTP six other u.v.-absorbing compounds were formed. The major component, other than CTP, co-chromatographed with 3',5'-cyclic CMP in both t.1.c. systems and on both the paired-ion and reverse phase h.p.1.c. systems described previously (Brown et al., 1982) . The identity of this compound was unambiguously confirmed Abbreviations used: CID. collison-induced dissociation; f.a.b.. fast atom bombardment; m.i.k.e.s.. mass analysed ion kinetic energy spec t r um . by f.a.b. mass spectrometry, which produced a protonated molecular ion [MH] ' at m / z 306, followed by CID/m.i.k.e.s. scanning of this m / z 306 ion, yielding a spectrum identical to that from authentic cyclic C M P including the characteristic fragments at m / z 154 and 140 (Newton et al., 1983; 1984h,c; Kingston et al., 1984 Kingston et al., , 1985 .
The other, minor, products obtained were purified by t.1.c. and examined by f.a.b. mass spectrometry. Two of the products which co-chromatographed with CDP and CMP had strong ions at m/z 404,426,448,496 and 516, and at mjz 324, 346, 368, 416 and 438, respectively, and 500. These spectra were consistent with the compounds being cytidine 3',5'-cyclic pyrophosphate and cytidine 2'-monophosphate 3',5'-cyclic monophosphate, both of which have an M , of 385. These identities were confirmed by partial hydrolysis and chromatographic identification of the major products as CDP from the cyclic pyrophosphate and cyclic CMP from the phosphorylated cyclic CMP. The existence of a second phosphate moiety in each of these products was demonstrated by use of a CTP substrate radiolabelled with both I4C and 32P; the cytidine cyclic pyrophosphate and phosporylated cyclic C M P had a I2P/l4C ratio similar to that of CDP and approximately double that of cyclic CMP. The final unknown fraction produced strong ions on f.a.b. at mjz 421, 435, 443, 457, 465, 479, 513, 527, 535 and 549 . Hydrolysis and chromatographic analyses indicated that this fraction contained two compounds, 2'-0-glutamyl cytidine 3',5'-cyclic monophosphate and 2'-0-aspartyl cytidine 3',5'-cyclic monophosphate; the products of hydrolysis included cyclic CMP in both cases together with either glutamate or aspartate. The ions observed in the Although the major product of the activity of the cytidylate cyclase preparation was found to be cyclic CMP, the presence of these four novel cytidine cyclic phosphate derivatives may well be the cause of the conflicting reports concerning cytidylate cyclase assay and radioimmunoassay of cyclic CMP. A number of separation procedures utilizing Dowex, PEI cellulose, QAE and SP Sephadex, boronate and alumina were examined in our attempts to isolate cyclic CMP from the substrate CTP and the other products of the cyclase assay. Analysis of the eluents by chromatography and mass spectrometry indicated the most effective to be a two-tier column (0.5cm x 7.0cm) with an 'upper layer of 2.5cm of QAE Sephadex on top of 0.5cm acid-washed alumina, eluted with 2.5ml of 0 . 0 3~-H C l . This system provided a reproducible cytidylate cyclase assay using ' H-, I4C-or "P-labelled CTP as substrate.
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